Skip to main content

Advertisement

SpringerLink
Log in

A PSP94-derived Peptide PCK3145 inhibits MMP-9 Secretion and Triggers CD44 Cell Surface Shedding: Implication in Tumor Metastasis

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

Purpose: PCK3145 is a synthetic peptide corresponding to amino acids 31–45 of prostate secretory protein 94, which can reduce experimental skeletal metastases and prostate tumor growth in vivo. Part of its biological action involves the reduction of circulating plasma matrix metalloproteinase (MMP)-9, a crucial mediator in extracellular matrix (ECM) degradation during tumor metastasis and cancer cell invasion. The antimetastatic mechanism of action of PCK3145 is however, not understood. Experimental design: HT-1080 fibrosarcoma cells were treated with PCK3145, and cell lysates used for immunoblot analysis of small GTPase RhoA and membrane type (MT)1-MMP protein expression. Conditioned media was used to monitor soluble MMP-9 gelatinolytic activity by zymography and protein expression by immunoblotting. RT-PCR was used to assess RhoA, MT1-MMP, MMP-9, RECK, and CD44 gene expression. Flow cytometry was used to monitor cell surface expression of CD44 and of membrane-bound MMP-9. Cell adhesion was performed on different purified ECM proteins, while cell migration was specifically performed on hyaluronic acid (HA). Results: We found that PCK3145 inhibited HT-1080 cell adhesion onto HA, laminin-1, and type-I collagen suggesting the common implication of the cell surface receptor CD44. In fact, PCK3145 triggered the shedding of CD44 from the cell surface into the conditioned media. PCK3145 also inhibited MMP-9 secretion and binding to the cell surface. This effect was correlated to increased RhoA and MT1-MMP gene and protein expression. Conclusions: Our data suggest that PCK3145 may antagonize tumor cell metastatic processes by inhibiting both MMP-9 secretion and its potential binding to its cell surface docking receptor CD44. Such mechanism may involve RhoA signaling and increase in MT1-MMP-mediated CD44 shedding. Together with its beneficial effects in clinical trials, this is the first demonstration of PCK3145 acting as a MMP secretion inhibitor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

ECM:

extracellular matrix

HRPC:

hormone-refractory prostate cancer

HA:

hyaluronan, hyaluronic acid

MMP-9:

matrix metalloproteinase-9

MT1-MMP:

membrane type-1 MMP

PMA:

phorbol 12-myristate 13-acetate

RECK:

reversion inducing cysteine-rich protein with Kazal motifs

TGF-β:

transforming growth factor-β

TNF:

tumor necrosis factor

References

  1. IJ Fidler (1995) ArticleTitleModulation of the organ microenvironment for the treatment of cancer metastasis J Natl Cancer Inst 87 1588–92 Occurrence Handle7563201

    PubMed  Google Scholar 

  2. JP Yang MA Finkelman MW Clarke (1998) ArticleTitleDetection of PSP94 and its specific binding sites in the prostate adenocarcinoma cell line LNCaP J Urol 160 2240–4 Occurrence Handle10.1097/00005392-199812010-00093 Occurrence Handle9817377

    Article  PubMed  Google Scholar 

  3. H Sakai T Tsurusaki S Kanda et al. (1999) ArticleTitlePrognostic significance of β-microseminoprotein mRNA expression in prostate cancer Prostate 38 278–84 Occurrence Handle10.1002/(SICI)1097-0045(19990301)38:4<278::AID-PROS3>3.0.CO;2-Z Occurrence Handle10075007

    Article  PubMed  Google Scholar 

  4. N Shukeir A Arakelian S Kadhim et al. (2003) ArticleTitleProstate secretory protein PSP94 decreases tumor growth and hypercalcemia of malignancy in a syngenic in vivo model of prostate cancer Cancer Res 63 2072–8 Occurrence Handle12727822

    PubMed  Google Scholar 

  5. N Shukeir A Arakelian G Chen et al. (2004) ArticleTitleA synthetic 15-mer peptide (PCK3145) derived from prostate secretory protein can reduce tumor growth, experimental skeletal metastases, and malignancy-associated hypercalcemia Cancer Res 64 5370–7 Occurrence Handle10.1158/0008-5472.CAN-04-0788 Occurrence Handle15289344

    Article  PubMed  Google Scholar 

  6. RE Hawkins L Daigneault R Cowan et al. (2005) ArticleTitleSafety and tolerability of PCK3145, a synthetic peptide derived from prostate secretory protein 94 (PSP94) in metastatic hormone-refractory prostate cancer Clin Prostate Cancer 4 91–9 Occurrence Handle16197609

    PubMed  Google Scholar 

  7. L Daigneault C Panchal HI Scher et al. (2005) ArticleTitleA synthetic peptide, PCK3145, for the treatment of hormone refractory prostate cancer ASCO Prostate Cancer Symposium 2005, Annual Meeting Proc 164 260

    Google Scholar 

  8. A Jemal E Ward X Wu et al. (2005) ArticleTitleGeographic patterns of prostate cancer mortality and variations in access to medical care in the United States Cancer Epidemiol Biomarkers Prev 14 590–5 Occurrence Handle10.1158/1055-9965.EPI-04-0522 Occurrence Handle15767335

    Article  PubMed  Google Scholar 

  9. DE Kleiner WG Stetler-Stevenson (1999) ArticleTitleMatrix metalloproteinases and metastasis Cancer Chemother Pharmacol 43 IssueIDSuppl S42–S51 Occurrence Handle10.1007/s002800051097 Occurrence Handle10357558

    Article  PubMed  Google Scholar 

  10. Z Dong RD Bonfil S Chinni et al. (2005) ArticleTitleMatrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue Am J Pathol 166 1173–86 Occurrence Handle15793297

    PubMed  Google Scholar 

  11. Q Yu I Stamenkovic (1999) ArticleTitleLocalization of matrix metalloproteinase-9 to the cell surface provides a mechanism for CD44-mediated tumor invasion Genes Dev 13 35–48 Occurrence Handle9887098

    PubMed  Google Scholar 

  12. LY Bourguignon Z Gunja-Smith N Iida et al. (1998) ArticleTitleCD44v(3, 8–10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells J Cell Physiol 176 206–15 Occurrence Handle10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3 Occurrence Handle9618160

    Article  PubMed  Google Scholar 

  13. B Annabi S Thibeault R Moumdjian et al. (2004) ArticleTitleHyaluronan cell surface binding is induced by type I collagen and regulated by caveolae in glioma cells J Biol Chem 279 21888–96 Occurrence Handle10.1074/jbc.M313694200 Occurrence Handle15016831

    Article  PubMed  Google Scholar 

  14. B Annabi M Bouzeghrane R Moumdjian et al. (2005) ArticleTitleProbing the infiltrating character of brain tumors: Inhibition of RhoA/ROK-mediated CD44 cell surface shedding from glioma cells by the green tea catechin EGCg J Neurochem 94 906–16 Occurrence Handle10.1111/j.1471-4159.2005.03256.x Occurrence Handle15992376

    Article  PubMed  Google Scholar 

  15. FH Silver RL Trelstad (1980) ArticleTitleType I collagen in solution. Structure and properties of fibril fragments J Biol Chem 255 9427–33 Occurrence Handle7410433

    PubMed  Google Scholar 

  16. B Annabi A Pilorget N Bousquet-Gagnon et al. (2001) ArticleTitleCalmodulin inhibitors trigger the proteolytic processing of membrane type-1 matrix metalloproteinase, but not its shedding in glioblastoma cells Biochem J 359 325–33 Occurrence Handle10.1042/0264-6021:3590325 Occurrence Handle11583578

    Article  PubMed  Google Scholar 

  17. S Mukhopadhyay HG Munshi S Kambhampati et al. (2004) ArticleTitleCalcium-induced matrix metalloproteinase-9 gene expression is differentially regulated by ERK1/2 and p38 MAPK in oral keratinocytes and oral squamous cell carcinoma J Biol Chem 279 33139–46 Occurrence Handle10.1074/jbc.M405194200 Occurrence Handle15180997

    Article  PubMed  Google Scholar 

  18. LT Liu HC Chang LC Chiang et al. (2003) ArticleTitleHistone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion Cancer Res 63 3069–72 Occurrence Handle12810630

    PubMed  Google Scholar 

  19. B Annabi MP Lachambre N Bousquet-Gagnon et al. (2001) ArticleTitleLocalization of membrane-type 1 matrix metalloproteinase in caveolae membrane domains Biochem J 353 547–53 Occurrence Handle10.1042/0264-6021:3530547 Occurrence Handle11171051

    Article  PubMed  Google Scholar 

  20. S Turcotte RR Desrosiers R Béliveau (2003) ArticleTitleHIF-1alpha mRNA and protein upregulation involves Rho GTPase expression during hypoxia in renal cell carcinoma J Cell Sci 116 2247–60 Occurrence Handle10.1242/jcs.00427 Occurrence Handle12697836

    Article  PubMed  Google Scholar 

  21. E Beaulieu Z Kachra N Mousseau et al. (1999) ArticleTitleMatrix metalloproteinases and their inhibitors in human pituitary tumors Neurosurgery 45 1432–40 Occurrence Handle10.1097/00006123-199912000-00033 Occurrence Handle10598711

    Article  PubMed  Google Scholar 

  22. V Rigot M Lehmann F Andre et al. (1998) ArticleTitleIntegrin ligation and PKC activation are required for migration of colon carcinoma cells J␣Cell Sci 111 3119–27 Occurrence Handle9739085

    PubMed  Google Scholar 

  23. W Hornebeck FX Maquart (2003) ArticleTitleProteolyzed matrix as a template for the regulation of tumor progression Biomed Pharmacother 57 223–30 Occurrence Handle10.1016/S0753-3322(03)00049-0 Occurrence Handle12888258

    Article  PubMed  Google Scholar 

  24. JE Draffin S McFarlane A Hill et al. (2004) ArticleTitleCD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells Cancer Res 64 5702–11 Occurrence Handle10.1158/0008-5472.CAN-04-0389 Occurrence Handle15313910

    Article  PubMed  Google Scholar 

  25. S Aaltomaa P Lipponen R Tammi et al. (2002) ArticleTitleStrong stromal hyaluronan expression is associated with PSA recurrence in local prostate cancer Urol Int 69 266–72 Occurrence Handle10.1159/000066123 Occurrence Handle12444281

    Article  PubMed  Google Scholar 

  26. H Miyake I Hara I Okamoto et al. (1998) ArticleTitleInteraction between CD44 and hyaluronic acid regulates human prostate cancer development J Urol 160 1562–6 Occurrence Handle10.1097/00005392-199810000-00115 Occurrence Handle9751413

    Article  PubMed  Google Scholar 

  27. D Naor RV Sionov D Ish-Shalom (1997) ArticleTitleCD44: Structure, function, and association with the malignant process Adv Cancer Res 71 241–319 Occurrence Handle9111868

    PubMed  Google Scholar 

  28. RA Sikes BE Nicholson KS Koeneman et al. (2004) ArticleTitleCellular interactions in the tropism of prostate cancer to bone Int J Cancer 110 497–503 Occurrence Handle10.1002/ijc.20153 Occurrence Handle15122581

    Article  PubMed  Google Scholar 

  29. K Tantivejkul LM Kalikin KJ Pienta (2004) ArticleTitleDynamic process of prostate cancer metastasis to bone J Cell Biochem 91 706–17 Occurrence Handle10.1002/jcb.10664 Occurrence Handle14991762

    Article  PubMed  Google Scholar 

  30. PV Hauschka AE Mavrakos MD Iafrati et al. (1986) ArticleTitleGrowth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose J Biol Chem 261 12665–74 Occurrence Handle3745206

    PubMed  Google Scholar 

  31. V Iyer K Pumiglia CM DiPersio (2005) ArticleTitleAlpha3beta1 integrin regulates MMP-9 mRNA stability in immortalized keratinocytes: A novel mechanism of integrin-mediated MMP gene expression J Cell Sci 118 1185–95 Occurrence Handle10.1242/jcs.01708 Occurrence Handle15728252

    Article  PubMed  Google Scholar 

  32. R Fridman M Toth I Chvyrkova et al. (2003) ArticleTitleCell surface association of matrix metalloproteinase-9 (gelatinase B) Cancer Metast Rev 22 153–66 Occurrence Handle10.1023/A:1023091214123

    Article  Google Scholar 

  33. Q Yu I Stamenkovic (2000) ArticleTitleCell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis Genes Dev 14 163–76 Occurrence Handle10652271

    PubMed  Google Scholar 

  34. D Danielpour (2005) ArticleTitleFunctions and regulation of transforming growth factor-beta (TGF-beta) in the prostate Eur J Cancer 41 846–57 Occurrence Handle10.1016/j.ejca.2004.12.027 Occurrence Handle15808954

    Article  PubMed  Google Scholar 

  35. SM Wahl JB Allen BS Weeks et al. (1993) ArticleTitleTransforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocyte Proc Natl Acad Sci USA 90 4577–81 Occurrence Handle8506302

    PubMed  Google Scholar 

  36. WC Duivenvoorden HW Hirte G Singh (1999) ArticleTitleTransforming growth factor beta1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells Clin Exp Metast 17 27–34 Occurrence Handle10.1023/A:1026404227624

    Article  Google Scholar 

  37. I Sehgal TC Thompson (1999) ArticleTitleNovel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines Mol Biol Cell 10 407–16 Occurrence Handle9950685

    PubMed  Google Scholar 

  38. HC DeGrendele P Estess MH Siegelman (1997) ArticleTitleRequirement for CD44 in activated T cell extravasation into an inflammatory site Science 278 672–5 Occurrence Handle10.1126/science.278.5338.672 Occurrence Handle9381175

    Article  PubMed  Google Scholar 

  39. R Ristamaki H Joensuu S Jalkanen (1996) ArticleTitleDoes soluble CD44 reflect the clinical behavior of human cancer? Curr Top Microbiol Immunol 213 155–66 Occurrence Handle8815003

    PubMed  Google Scholar 

  40. J Lohi J Keski-Oja (1995) ArticleTitleCalcium ionophores decrease pericellular gelatinolytic activity via inhibition of 92-kDa gelatinase expression and decrease of 72-kDa gelatinase activation J Biol Chem 270 17602–9 Occurrence Handle10.1074/jbc.270.9.4689 Occurrence Handle7615567

    Article  PubMed  Google Scholar 

  41. V Michalaki K Syrigos P Charles et al. (2004) ArticleTitleSerum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer Br J Cancer 90 2312–6 Occurrence Handle15150588

    PubMed  Google Scholar 

  42. N Suenaga H Mori Y Itoh M Seiki (2005) ArticleTitleCD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase Oncogene 24 859–68 Occurrence Handle10.1038/sj.onc.1208258 Occurrence Handle15558018

    Article  PubMed  Google Scholar 

  43. E Sahai CJ Marshall (2002) ArticleTitleRHO-GTPases and cancer Nat Rev Cancer 2 133–42 Occurrence Handle10.1038/nrc725 Occurrence Handle12635176

    Article  PubMed  Google Scholar 

  44. LY Bourguignon (2001) ArticleTitleCD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression J Mammary Gland Biol Neoplasia 6 287–97 Occurrence Handle10.1023/A:1011371523994 Occurrence Handle11547898

    Article  PubMed  Google Scholar 

  45. M Shi K Dennis JJ Peschon R Chandrasekaran K Mikecz (2001) ArticleTitleAntibody-induced shedding of CD44 from adherent cells is linked to the assembly of the cytoskeleton J Immunol 167 123–31 Occurrence Handle11418640

    PubMed  Google Scholar 

  46. Y Kawano I Okamoto D Murakami H Itoh M Yoshida S Ueda H Saya (2000) ArticleTitleRas oncoprotein induces CD44 cleavage through phosphoinositide 3-OH kinase and the rho family of small G proteins J Biol Chem 275 29628–35 Occurrence Handle10.1074/jbc.M002440200 Occurrence Handle10896935

    Article  PubMed  Google Scholar 

  47. I Abecassis B Olofsson M Schmid et al. (2003) ArticleTitleRhoA induces MMP-9 expression at CD44 lamellipodial focal complexes and promotes HMEC-1 cell invasion Exp Cell Res 291 363–76 Occurrence Handle10.1016/j.yexcr.2003.08.006 Occurrence Handle14644158

    Article  PubMed  Google Scholar 

  48. A Perschl J Lesley N English et al. (1995) ArticleTitleTransmembrane domain of CD44 is required for its detergent insolubility in fibroblasts J Cell Sci 108 1033–41 Occurrence Handle7542666

    PubMed  Google Scholar 

  49. D Gingras F Gauthier S Lamy et al. (1998) ArticleTitleLocalization of RhoA GTPase to endothelial caveolae-enriched membrane domains Biochem Biophys Res Commun 247 888–93 Occurrence Handle10.1006/bbrc.1998.8885 Occurrence Handle9647788

    Article  PubMed  Google Scholar 

  50. TM Williams MP Lisanti (2005) ArticleTitleCaveolin-1 in oncogenic transformation, cancer, and metastasis Am J Physiol Cell Physiol 288 C494–C506 Occurrence Handle10.1152/ajpcell.00458.2004 Occurrence Handle15692148

    Article  PubMed  Google Scholar 

  51. TM Williams F Medina I Badano RB Hazan J Hutchinson WJ Muller NG Chopra PE Scherer RG Pestell MP Lisanti (2004) ArticleTitleCaveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion J Biol Chem 279 51630–46 Occurrence Handle10.1074/jbc.M409214200 Occurrence Handle15355971

    Article  PubMed  Google Scholar 

  52. TM Williams GS Hassan J Li AW Cohen F Medina PG Frank RG Pestell D Di Vizio M Loda MP Lisanti (2005) ArticleTitleCaveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: Genetic ablation of Cav-1 delays advanced prostate tumor development in TRAMP mice J Biol Chem 280 25134–45 Occurrence Handle10.1074/jbc.M501186200 Occurrence Handle15802273

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratoire d’Oncologie Moléculaire, Département de Chimie-Biochimie, Université du Québec à Montréal, Montreal, Quebec, Canada

    Borhane Annabi & Jean-Christophe Currie

  2. Laboratoire de Médecine Moléculaire, Centre de Cancérologie Charles-Bruneau, Hôpital Sainte-Justine, Université du Québec à Montréal, Succ. Centre-ville, H3C 3P8, C.P. 8888, Montreal, Quebec, Canada

    Mounia Bouzeghrane & Richard Béliveau Phd

  3. Christie Hospital NHS Trust, Manchester, UK

    Robert Hawkins

  4. Procyon BioPharma, Inc., Montreal, Quebec, Canada

    Hélène Dulude, Luc Daigneault, Marcia Ruiz, Jan Wisniewski, Seema Garde, Chandra Panchal & Jinzi J. Wu

  5. Department of Medicine, Physiology, and Oncology, McGill University Health Centre, Montreal, Quebec, Canada

    Shafaat A. Rabbani

Authors
  1. Borhane Annabi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mounia Bouzeghrane
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jean-Christophe Currie
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Robert Hawkins
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hélène Dulude
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Luc Daigneault
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Marcia Ruiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jan Wisniewski
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Seema Garde
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Shafaat A. Rabbani
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Chandra Panchal
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Jinzi J. Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Richard Béliveau Phd
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Richard Béliveau Phd.

Additional information

*These authors contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Annabi, B., Bouzeghrane, M., Currie, JC. et al. A PSP94-derived Peptide PCK3145 inhibits MMP-9 Secretion and Triggers CD44 Cell Surface Shedding: Implication in Tumor Metastasis. Clin Exp Metastasis 22, 429–439 (2005). https://doi.org/10.1007/s10585-005-2669-1

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10585-005-2669-1

Keywords

Search

Navigation